Exosome-Based Therapeutics and Technologies
Exosomes are rapidly emerging as transformative tools in clinical medicine, offering innovative solutions for diagnostics, targeted drug delivery, and regenerative therapies.
These naturally derived, nanoscale vesicles carry proteins, lipids, and genetic material between cells, enabling precise delivery of therapeutic agents or genes to diseased tissues — including those affected by cancer and neurodegenerative disorders.
In regenerative medicine, stem cell–derived exosomes play a vital role in tissue repair and inflammation modulation, enhancing recovery in conditions such as orthopedic injuries, cardiac, and pulmonary diseases. Their application as biomarkers further supports non-invasive disease detection and real-time monitoring.
While the potential of exosome-based therapies is immense, scalable manufacturing and regulatory standardization remain critical for clinical translation.
At CLONOVA, we are advancing the field with a novel exosome manufacturing process utilizing STR single-use bioreactors through a suspension cell culture platform — enabling consistent, scalable, and high-quality exosome production for therapeutic and diagnostic applications.
